MITF
MOLECULAR TARGETmelanocyte inducing transcription factor
MITF (melanocyte inducing transcription factor) is targeted by 45 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MITF
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
About MITF as a Drug Target
MITF (melanocyte inducing transcription factor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 45 compounds with documented MITF interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MITF inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.